Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke

Journal of Neurology

Volumn 252, Issue 11, 2005, Pages 1316-1321

  De Schryver, E L L M ^a   Van Gijn, J ^a   Kappelle, L J ^a   Koudstaal, P J ^b   Algra, A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adherence; Compliance; Prevention; Secondary; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG DOSE REDUCTION; FATIGUE; FEMALE; FOLLOW UP; HAIR LOSS; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SECONDARY PREVENTION; STATISTICAL MODEL; STOMACH HEMORRHAGE; STROKE; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANTICOAGULANTS; ASPIRIN; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 28144447571     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-005-0858-0     Document Type: Article

References (15)

1. Cleemput I, Kesteloot K (2002) Economic implications of non-compliance in health care. Lancet 359:2129-2130
2. Donovan JL (1995) Patient decision making. The missing ingredient in compliance research. Int J Technol Assess Health Care 11:443-455
3. EAFT (European Atrial Fibrillation Trial) Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342:1255-1262
4. Gencheva E, Sloan M, Leurgans S, Raman R, Harris Y, Gorelick P (2004) Attrition and non-compliance in secondary stroke prevention trials. Neuroepidemiology 23:61-66
5. Hamann GF, Weimar C, Glahn J, Busse O, Diener HC (2003) Adherence to secondary stroke prevention strategies-results from the German Stroke Data Bank. Cerebrovasc Dis 15:282-288
6. Hillen T, Dundas R, Lawrence E, Stewart JA, Rudd AG, Wolfe CD (2000) Antithrombotic and antihypertensive management 3 months after ischemic stroke: a prospective study in an inner city population. Stroke 31:469-475
7. Mushlin AI, Appel FA (1977) Diagnosing potential noncompliance. Physicians' ability in a behavioral dimension of medical care. Arch Intern Med 137:318-321
8. Rojas-Fernandez CH, Kephart GC, Sketris IS, Kass K (1999) Underuse of acetylsalicylic acid in individuals with myocardial infarction, ischemic heart disease or stroke: data from the 1995 population-based Nova Scotia Health Survey. Can J Cardiol 15:291-296
9. Sappok T, Faulstich A, Stuckert E, Kruck H, Marx P, Koennecke HC (2001) Compliance with secondary prevention of ischemic stroke: a prospective evaluation. Stroke 32:1884-1889
10. Schroeder K, Fahey T, Ebrahim S (2004) How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med 164:722-732
11. Smith NL, Psaty BM, Heckbert SR, Tracy RP, Cornell ES (1999) The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. J Clin Epidemiol 52:143-146
12. Svensson S, Kjellgren KI, Ahlner J, Saljo R (2000) Reasons for adherence with antihypertensive medication. Int J Cardiol 76:157-163
13. The Dutch TIA Trial Study Group (1991) A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 325:1261-1266
14. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group (1997) A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 42:857-865
15. Vermeire E, Hearnshaw H, Van Royen P, Denekens J (2001) Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 26:331-342